Latest Insider Transactions at Inovio Pharmaceuticals, Inc. (INO)
This section provides a real-time view of insider transactions for Inovio Pharmaceuticals, Inc. (INO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INOVIO PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INOVIO PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 26
2023
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
42,273
-15.12%
|
$42,273
$1.28 P/Share
|
Feb 26
2023
|
Jacqueline Elizabeth Shea Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
92,778
+24.55%
|
-
|
Feb 26
2023
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
23,334
+1.27%
|
-
|
Jan 15
2023
|
Jay Shepard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,273
+9.76%
|
-
|
Aug 11
2022
|
David B. Weiner Director |
SELL
Open market or private sale
|
Direct |
11,875
-1.31%
|
$23,750
$2.66 P/Share
|
Aug 11
2022
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,875
+1.3%
|
$23,750
$2.16 P/Share
|
Jul 20
2022
|
Simon X Benito Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.59%
|
$4,000
$2.25 P/Share
|
Jul 20
2022
|
Simon X Benito Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+2.52%
|
$4,000
$2.2 P/Share
|
May 16
2022
|
Lota S. Zoth Director |
SELL
Open market or private sale
|
Direct |
3,600
-8.37%
|
$3,600
$1.98 P/Share
|
May 16
2022
|
David B. Weiner Director |
SELL
Open market or private sale
|
Direct |
9,000
-1.0%
|
$9,000
$1.95 P/Share
|
May 13
2022
|
Wendy L Yarno Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+24.61%
|
-
|
May 13
2022
|
Ann Calby Miller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+27.47%
|
-
|
May 13
2022
|
Simon X Benito Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+19.29%
|
-
|
May 13
2022
|
Lota S. Zoth Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+29.5%
|
-
|
May 13
2022
|
Jay Shepard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+33.8%
|
-
|
May 13
2022
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+1.96%
|
-
|
May 13
2022
|
Roger D Dansey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+50.0%
|
-
|
Mar 25
2022
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,247
-8.65%
|
$21,741
$3.63 P/Share
|
Mar 25
2022
|
Jacqueline Elizabeth Shea Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+16.59%
|
-
|
Mar 21
2022
|
Ann Calby Miller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,273
+12.64%
|
-
|
Mar 16
2022
|
Simon X Benito Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.37%
|
$6,000
$3.16 P/Share
|
Mar 16
2022
|
Simon X Benito Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+3.26%
|
$4,000
$2.2 P/Share
|
Mar 14
2022
|
David B. Weiner Director |
SELL
Open market or private sale
|
Direct |
4,083
-0.46%
|
$12,249
$3.2 P/Share
|
Mar 11
2022
|
Peter Kies CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
31,410
-14.91%
|
$94,230
$3.22 P/Share
|
Mar 11
2022
|
Peter Kies CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
59,737
+22.09%
|
-
|
Mar 11
2022
|
Jong Joseph Kim Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
39,698
-2.71%
|
$119,094
$3.22 P/Share
|
Mar 11
2022
|
Jong Joseph Kim Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
139,387
+8.7%
|
-
|
Mar 11
2022
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,667
+1.3%
|
-
|
Mar 11
2022
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,974
-27.9%
|
$77,922
$3.22 P/Share
|
Mar 11
2022
|
Jacqueline Elizabeth Shea Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
59,737
+39.08%
|
-
|
Mar 11
2022
|
Laurent Humeau Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
41,316
-13.3%
|
$123,948
$3.22 P/Share
|
Mar 11
2022
|
Laurent Humeau Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
119,474
+27.77%
|
-
|
Mar 09
2022
|
David B. Weiner Director |
SELL
Open market or private sale
|
Direct |
4,083
-0.46%
|
$12,249
$3.33 P/Share
|
Mar 08
2022
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,666
+1.31%
|
-
|
Mar 08
2022
|
Laurent Humeau Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,882
-6.72%
|
$20,646
$3.26 P/Share
|
Mar 08
2022
|
Laurent Humeau Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,900
+16.26%
|
-
|
Mar 08
2022
|
Jong Joseph Kim Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,142
-1.35%
|
$54,426
$3.26 P/Share
|
Mar 08
2022
|
Jong Joseph Kim Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
63,700
+4.53%
|
-
|
Mar 08
2022
|
Peter Kies CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,287
-6.96%
|
$33,861
$3.26 P/Share
|
Mar 08
2022
|
Peter Kies CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,466
+11.68%
|
-
|
Feb 26
2022
|
Jong Joseph Kim Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,045
-1.55%
|
$60,135
$3.22 P/Share
|
Feb 26
2022
|
Jong Joseph Kim Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
68,767
+5.03%
|
-
|
Feb 26
2022
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,764
-24.39%
|
$32,292
$3.22 P/Share
|
Feb 26
2022
|
Jacqueline Elizabeth Shea Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,545
+33.81%
|
-
|
Feb 26
2022
|
Laurent Humeau Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,545
-9.38%
|
$25,635
$3.22 P/Share
|
Feb 26
2022
|
Laurent Humeau Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,545
+19.83%
|
-
|
Feb 26
2022
|
Peter Kies CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,555
-8.19%
|
$37,665
$3.22 P/Share
|
Feb 26
2022
|
Peter Kies CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,545
+12.82%
|
-
|
Feb 26
2022
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,667
+1.33%
|
-
|
Jan 19
2022
|
Simon X Benito Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.37%
|
$8,000
$4.27 P/Share
|